Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

In this quiz, the June 2022 approval of baricitinib is highlighted as the first treatment approved for alopecia areata.

Clinical Quiz: BRAVE-AA and Baricitinib in Alopecia Areata  

Shadi Kourosh, MD, MPH, joins The Medical Sisterhood to discuss advocacy, mentorship, and the empowerment of women in medicine. 

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

These retrospective data highlight maternal alopecia areata’s link with the risk of adverse birth outcomes among infants.

Infants Born to Mothers with Alopecia Areata at Increased Risk of Adverse Outcomes

These findings suggest that zinc and vitamin D levels may function as a disease severity indicator for patients with alopecia areata. 

Low Serum Vitamin D, Zinc Shown to be Risk Factor for Alopecia Areata

These data highlight the long-term efficacy of baricitinib, a JAK 1/2 inhibitor, for patients with severe alopecia areata in a real-world setting.

Baricitinib Effective, Safe Over 52 Weeks for Severe Alopecia Areata

These data highlight long-term complications related to COVID-19 in terms of skin conditions, a continuing concern for many patients.

COVID-19 May Increase Risk of Vitiligo, Chronic Urticaria, Alopecia Areata

A new cohort study including over 6 million participants has found an increased likelihood of Behçet disease, alocpecia, bulbous pemphigoid and other disorders post-COVID infection.

Autoimmune/Inflammatory Tissue Disorders Associated With COVID-19 Infection

This Fall Clinical Dermatology Conference interview with Song features a discussion regarding several useful clinical pearls for dermatologists.

2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD

In this interview, Bunick spoke about the contents of his Fall Clinical Dermatology presentation specifically regarding mechanisms of action and safety of systemic therapies.

Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action

In this interview with Chovatiya, he highlights some of the elements of the presentations being given at the Fall Clinical Dermatology conference in Las Vegas.
